The store will not work correctly when cookies are disabled.
N-(4-amino-3-(trifluoromethyl)phenyl)-4-chlorobenzenesulfonamide
ID: ALA4795755
PubChem CID: 162673626
Max Phase: Preclinical
Molecular Formula: C13H10ClF3N2O2S
Molecular Weight: 350.75
Molecule Type: Unknown
Associated Items:
Names and Identifiers
Canonical SMILES: Nc1ccc(NS(=O)(=O)c2ccc(Cl)cc2)cc1C(F)(F)F
Standard InChI: InChI=1S/C13H10ClF3N2O2S/c14-8-1-4-10(5-2-8)22(20,21)19-9-3-6-12(18)11(7-9)13(15,16)17/h1-7,19H,18H2
Standard InChI Key: KTJFMJRAYXBLOZ-UHFFFAOYSA-N
Molfile:
RDKit 2D
22 23 0 0 0 0 0 0 0 0999 V2000
14.2018 -15.5803 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
13.7973 -14.8745 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
13.3884 -15.5777 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
15.2157 -14.8745 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.2145 -15.6940 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.9226 -16.1030 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.6322 -15.6936 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.6294 -14.8709 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.9208 -14.4656 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.5079 -14.4661 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
13.0924 -14.4664 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.0959 -13.6486 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.3889 -13.2403 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.6803 -13.6491 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.6832 -14.4705 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.3907 -14.8752 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.3406 -16.1010 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
15.9224 -16.9202 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.2146 -17.3286 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
16.6300 -17.3290 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
15.9146 -17.7347 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
10.9720 -13.2416 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
2 1 2 0
3 2 2 0
4 5 2 0
5 6 1 0
6 7 2 0
7 8 1 0
8 9 2 0
9 4 1 0
4 10 1 0
10 2 1 0
2 11 1 0
11 12 2 0
12 13 1 0
13 14 2 0
14 15 1 0
15 16 2 0
16 11 1 0
7 17 1 0
6 18 1 0
18 19 1 0
18 20 1 0
18 21 1 0
14 22 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 350.75 | Molecular Weight (Monoisotopic): 350.0104 | AlogP: 3.74 | #Rotatable Bonds: 3 |
Polar Surface Area: 72.19 | Molecular Species: NEUTRAL | HBA: 3 | HBD: 2 |
#RO5 Violations: ┄ | HBA (Lipinski): 4 | HBD (Lipinski): 3 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 8.26 | CX Basic pKa: 2.31 | CX LogP: 3.11 | CX LogD: 3.06 |
Aromatic Rings: 2 | Heavy Atoms: 22 | QED Weighted: 0.83 | Np Likeness Score: -1.82 |
References
1. Xu F,Zhao Y,Zhou H,Li C,Zhang X,Hou T,Qu L,Wei L,Wang J,Liu Y,Liang X. (2020) Synthesis and evaluation of 3-(4-(phenoxymethyl)phenyl)propanoic acid and N-phenylbenzenesulfonamide derivatives as FFA4 agonists., 30 (24): [PMID:33127539] [10.1016/j.bmcl.2020.127650] |